BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

In vivo adenine base editing corrects SCN1A deficiency in Dravet syndrome

BC Staff
June 3, 2026 12:29 AM UTC

BCIQ Company Profiles

Broad Institute of Mit and Harvard

The Children's Hospital of Philadelphia

The Jackson Laboratory

BCIQ Target Profiles

Sodium voltage-gated channel alpha subunit 1 (Nav1.1) (SCN1A)

BCIQ Company Profiles

Broad Institute of Mit and Harvard

The Children's Hospital of Philadelphia

The Jackson Laboratory

BCIQ Target Profiles

Sodium voltage-gated channel alpha subunit 1 (Nav1.1) (SCN1A)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2026 BioCentury Inc. All Rights Reserved.
Copyright © 2026 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS